Stoke Therapeutics, Inc. STOK
27.26 USD +0.58 (+2.17%)
As ofNov 16, 2026, 11:12 AM EST
26.49 Day range 27.50
22.05 52-week range 40.22
- YTD
- -14.11%
- 1 year
- +2.83%
News
benzinga.com Stoke Therapeutics Q3 2026 Earnings Call Transcript Stoke Therapeutics (NASDAQ:STOK) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com Stoke Therapeutics Q3 EPS $(1.08) Misses $(0.93) Estimate, Sales $11.255M Beat $8.185M Estimate Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0.93) by 16.13 percent. This is a 66.15 percent decrease over losses…
